TY - JOUR
T1 - Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle-invasive and non-organ confined disease in patients with upper tract urothelial carcinoma
AU - Favaretto, Ricardo L.
AU - Shariat, Shahrokh F.
AU - Savage, Caroline
AU - Godoy, Guilherme
AU - Chade, Daher C.
AU - Kaag, Matthew
AU - Bochner, Bernard H.
AU - Coleman, Jonathan
AU - Dalbagni, Guido
PY - 2012/1
Y1 - 2012/1
N2 - Objective: • To create a preoperative multivariable model to identify patients at risk of muscle-invasive (pT2+) upper tract urothelial carcinoma (UTUC) and/or non-organ confined (pT3+ or N+) UTUC (NOC-UTUC) who potentially could benefit from radical nephroureterectomy (RNU), neoadjuvant chemotherapy and/or an extended lymph node dissection. Patients and Methods: • We retrospectively analysed data from 324 consecutive patients treated with RNU between 1995 and 2008 at a tertiary cancer centre. • Patients with muscle-invasive bladder cancer were excluded, resulting in 274 patients for analysis. • Logistic regression models were used to predict pT2+ and NOC-UTUC. Pre-specified predictors included local invasion (i.e. parenchymal, renal sinus fat, or periureteric) on imaging, hydronephrosis on imaging, high-grade tumours on ureteroscopy, and tumour location on ureteroscopy. • Predictive accuracy was measured by the area under the curve (AUC). Results: • The median follow-up for patients without disease recurrence or death was 4.2 years. • Overall, 49% of the patients had pT2+, and 30% had NOC-UTUC at the time of RNU. • In the multivariable analysis, only local invasion on imaging and ureteroscopy high grade were significantly associated with pathological stage. • AUC to predict pT2+ and NOC-UTUC were 0.71 and 0.70, respectively. Conclusions: • We designed a preoperative prediction model for pT2+ and NOC-UTUC, based on readily available imaging and ureteroscopic grade. • Further research is needed to determine whether use of this prediction model to select patients for conservative management vs RNU, neoadjuvant chemotherapy, and/or extended lymphadenectomy will improve patient outcomes.
AB - Objective: • To create a preoperative multivariable model to identify patients at risk of muscle-invasive (pT2+) upper tract urothelial carcinoma (UTUC) and/or non-organ confined (pT3+ or N+) UTUC (NOC-UTUC) who potentially could benefit from radical nephroureterectomy (RNU), neoadjuvant chemotherapy and/or an extended lymph node dissection. Patients and Methods: • We retrospectively analysed data from 324 consecutive patients treated with RNU between 1995 and 2008 at a tertiary cancer centre. • Patients with muscle-invasive bladder cancer were excluded, resulting in 274 patients for analysis. • Logistic regression models were used to predict pT2+ and NOC-UTUC. Pre-specified predictors included local invasion (i.e. parenchymal, renal sinus fat, or periureteric) on imaging, hydronephrosis on imaging, high-grade tumours on ureteroscopy, and tumour location on ureteroscopy. • Predictive accuracy was measured by the area under the curve (AUC). Results: • The median follow-up for patients without disease recurrence or death was 4.2 years. • Overall, 49% of the patients had pT2+, and 30% had NOC-UTUC at the time of RNU. • In the multivariable analysis, only local invasion on imaging and ureteroscopy high grade were significantly associated with pathological stage. • AUC to predict pT2+ and NOC-UTUC were 0.71 and 0.70, respectively. Conclusions: • We designed a preoperative prediction model for pT2+ and NOC-UTUC, based on readily available imaging and ureteroscopic grade. • Further research is needed to determine whether use of this prediction model to select patients for conservative management vs RNU, neoadjuvant chemotherapy, and/or extended lymphadenectomy will improve patient outcomes.
UR - http://www.scopus.com/inward/record.url?scp=83555166303&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=83555166303&partnerID=8YFLogxK
U2 - 10.1111/j.1464-410X.2011.10288.x
DO - 10.1111/j.1464-410X.2011.10288.x
M3 - Article
C2 - 21631698
AN - SCOPUS:83555166303
SN - 1464-4096
VL - 109
SP - 77
EP - 82
JO - BJU International
JF - BJU International
IS - 1
ER -